Indication

Plasmodium vivax malaria

Plasmodium vivax malaria is a mosquito-borne parasitic infection caused by the protozoan *Plasmodium vivax*, primarily targeting the hematologic and reticuloendothelial systems. Read more about Plasmodium vivax malaria

63 drugs 50 manufacturers

Advertisement

Drugs that treat it

Common Plasmodium vivax malaria therapies.

Showing 1–9 of 63 drugs

CHLOROQUINE PHOSPHATE

ANTIRHEUMATIC AGENTS (DMARDS, NON-BIOLOGIC)·PLASMODIUM FALCIPARUM MALARIA·+4
RISING PHARM
Filter & compare in the drug finder →Opens the drug finder with Plasmodium vivax malaria preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Plasmodium vivax malaria.

Plasmodium vivax malaria is a mosquito-borne parasitic infection caused by the protozoan *Plasmodium vivax*, primarily targeting the hematologic and reticuloendothelial systems.

The parasite selectively invades young erythrocytes (reticulocytes) via the Duffy antigen receptor, producing clinical manifestations characterized by paroxysmal fevers, chills, rigors, headache, fatigue, splenomegaly, and anemia.

A defining pathophysiological hallmark is the organism's capacity to form dormant hepatic stages known as hypnozoites, which can reactivate weeks to years later to trigger recurrent clinical relapses.

Although historically described as benign, repeated or severe infections can lead to serious complications such as profound anemia, thrombocytopenia, acute lung injury, and splenic rupture.

Personalize your experience

Follow Plasmodium vivax malaria and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it